Evaluation of the 3p21.3 tumour-suppressor gene cluster

被引:137
作者
Hesson, L. B.
Cooper, W. N.
Latif, F. [1 ]
机构
[1] Univ Birmingham, Biomed Res Inst, Div Reprod & Child Hlth, Dept Med & Mol Genet, Birmingham B15 2TT, W Midlands, England
[2] Univ Dundee, Coll Life Sci, MRC Protein Phosphorylat Unit, Dundee, Scotland
关键词
3p21.3; RASSFIA; epigenetics; tumor suppressor gene; JAAGSIEKTE SHEEP RETROVIRUS; HOMOZYGOUS DELETION REGION; HUMAN-CHROMOSOME; 3P21.3; CELL LUNG-CANCER; ADENOVIRUS E1A-ASSOCIATED PROTEIN; ISLAND PROMOTER HYPERMETHYLATION; FREQUENT EPIGENETIC INACTIVATION; CPG ISLAND; K-RAS; ABERRANT METHYLATION;
D O I
10.1038/sj.onc.1210547
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Deletions of the 3p21.3 region are a frequent and early event in the formation of lung, breast, kidney and other cancers. Intense investigation of allelic losses and the discovery of overlapping homozygous deletions in lung and breast tumour-cell lines have defined a minimal critical 120 kb deletion region containing eight genes and likely to harbor one or more tumour-suppressor genes (TSGs). The candidate genes are HYAL2, FUS1, Ras-associated factor 1 (RASSF1), BLU/ZMYND10, NPR2L, 101F6, PL6 and CACNA2D2. Recent research indicates that several of these genes can suppress the growth of lung and other tumour cells. Furthermore, some genes (RASSF1A and BLU/ZMYND10) are very frequently inactivated by non-classical mechanisms such as promoter hypermethylation resulting in loss of expression. These data indicate that the 120 kb critical deletion region at 3p21.3 may represent a TSG cluster with preferential inactivation of particular genes depending on tumour type. The eight genes within this region and their potential role in cancer will be the focus of this review.
引用
收藏
页码:7283 / 7301
页数:19
相关论文
共 121 条
  • [1] Abe M, 2005, CANCER RES, V65, P828
  • [2] Epigenetic inactivation of the candidate 3p21.3 suppressor gene BLU in human cancers
    Agathanggelou, A
    Dallol, A
    Zöchbauer-Müller, S
    Morrissey, C
    Honorio, S
    Hesson, L
    Martinsson, T
    Fong, KM
    Kuo, MJ
    Yuen, PW
    Maher, ER
    Minna, JD
    Latif, F
    [J]. ONCOGENE, 2003, 22 (10) : 1580 - 1588
  • [3] Role of the ras-association domain family 1 tumor suppressor gene in human cancers
    Agathanggelou, A
    Cooper, WN
    Latif, F
    [J]. CANCER RESEARCH, 2005, 65 (09) : 3497 - 3508
  • [4] Agathanggelou A, 2003, CANCER RES, V63, P5344
  • [5] Transcriptional regulation of cyclin A2 by RASSF1A through the enhanced binding of p120E4F to the cyclin A2 promoter
    Ahmed-Choudhury, J
    Agathanggelou, A
    Fenton, SL
    Ricketts, C
    Clark, GJ
    Maher, ER
    Latif, F
    [J]. CANCER RESEARCH, 2005, 65 (07) : 2690 - 2697
  • [6] The Ras effector RASSF2 is a novel tumor-suppressor gene in human colorectal cancer
    Akino, K
    Toyota, M
    Suzuki, H
    Mita, H
    Sasaki, Y
    Ohe-Toyota, M
    Issa, JPJ
    Hinoda, Y
    Imai, K
    Tokino, T
    [J]. GASTROENTEROLOGY, 2005, 129 (01) : 156 - 169
  • [7] Alden KJ, 2001, J PHARMACOL EXP THER, V297, P727
  • [8] ETO, a target of t(8;21) in acute leukemia, makes distinct contacts with multiple histone deacetylases and binds mSin3A through its oligomerization domain
    Amann, JM
    Nip, J
    Strom, DK
    Lutterbach, B
    Harada, H
    Lenny, N
    Downing, JR
    Meyers, S
    Hiebert, SW
    [J]. MOLECULAR AND CELLULAR BIOLOGY, 2001, 21 (19) : 6470 - 6483
  • [9] Cache -: a signaling domain common to animal Ca2+ channel subunits and a class of prokaryotic chemotaxis receptors
    Anantharaman, V
    Aravind, L
    [J]. TRENDS IN BIOCHEMICAL SCIENCES, 2000, 25 (11) : 535 - 537
  • [10] Norel inhibits tumor cell growth independent of Ras or the MST1/2 kinases
    Aoyama, Y
    Avruch, J
    Zhang, XF
    [J]. ONCOGENE, 2004, 23 (19) : 3426 - 3433